Treatment duration of checkpoint inhibitors for NSCLC

Jordi Remon, Jessica Menis, Sandrine Aspeslagh, Benjamin Besse

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	835-837
Number of pages	3
Journal	The Lancet Respiratory Medicine
Volume	7
Issue number	10
DOIs	https://doi.org/10.1016/S2213-2600(19)30192-4
Publication status	Published - Oct 2019

Access to Document

@article{196f82f75ef44ca892caccf19b663cad,

title = "Treatment duration of checkpoint inhibitors for NSCLC",

author = "Jordi Remon and Jessica Menis and Sandrine Aspeslagh and Benjamin Besse",

year = "2019",

month = oct,

doi = "10.1016/S2213-2600(19)30192-4",

language = "English",

volume = "7",

pages = "835--837",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "10",

}

TY - JOUR

T1 - Treatment duration of checkpoint inhibitors for NSCLC

AU - Remon, Jordi

AU - Menis, Jessica

AU - Aspeslagh, Sandrine

AU - Besse, Benjamin

PY - 2019/10

Y1 - 2019/10

U2 - 10.1016/S2213-2600(19)30192-4

DO - 10.1016/S2213-2600(19)30192-4

M3 - Article

C2 - 31401050

VL - 7

SP - 835

EP - 837

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

SN - 2213-2600

IS - 10

ER -